Lyell Immunopharma, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

Lyell Immunopharma, Inc. has filed 331 SEC EDGAR filings since 20 Mar 2020

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 101-125 of 331 matching filings.

Per page

25

Current page

5

3

3 filing

Filing date: 11 Jun 2025
Reporting date: 09 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Jun 2025
Reporting date: 09 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Jun 2025
Reporting date: 09 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40502

8-K

Filing date: 09 Jun 2025
Reporting date: 09 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40502

8-K

Filing date: 28 May 2025
Reporting date: 27 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40502

8-K

Filing date: 21 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date: 15 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-40502

10-Q

Filing date: 13 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40502

8-K

Filing date: 13 May 2025
Reporting date: 13 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 001-40502

ARS

Filing date: 21 Apr 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-40502

DEF 14A

Filing date: 21 Apr 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRE 14A File 001-40502

PRE 14A

Filing date: 10 Apr 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40502

8-K

Filing date: 01 Apr 2025
Reporting date: 27 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 25 Mar 2025
Reporting date: 21 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Mar 2025
Reporting date: 14 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Mar 2025
Reporting date: 17 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Mar 2025
Reporting date: 14 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-285717

S-8

Filing date: 11 Mar 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .